1200.89.10005 Boehringer Ingelheim Investigational Site

Durham, North Carolina

0 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms

Studies at this site

• Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer — Completed